Topic resource collection
Approved comparison material connected to this topic.
774 resourcesRead both sides
BPC-157 VEGF/PDGF upregulation for angiogenesis and oligodendrocyte support eNOS activation, reduced oxidative stress Subcutaneous or oral (15% bioavailability orally) 40–60% reduction in demyelination severity Strongest preclini…
Epitalon (AEDG) Direct telomerase activation via TERT upregulation Lengthens telomeres 400–500 bp in 60% of users (6-month human trial data) St. Petersburg Institute trial (n=266); in vitro TRAP assays showing 33–45% activity inc…
The table below compares the three primary melanotropic peptides used in tan optimization research based on receptor selectivity, typical research dosing, melanogenic potency, and experimental applications. This comparison helps …
GLP-1 Receptor Agonists Metabolic pathway studies, insulin signaling research ≥98% 18–24 months Bacteriostatic water or PBS High demand in diabetes and obesity research; require cold-chain shipping to prevent aggregation GHRP-2, …
MOTS-C Mitochondrial transcription upregulation, increases ATP synthesis 30–40% Cell Metabolism 2021: improved glucose uptake 35%, reduced lactate during exertion Yes. Mitochondrial adaptations persist 8+ weeks after dosing stops…
Before you begin. This table compares mechanism, target site, and research application for each peptide. The 'Professional Assessment' column addresses when each peptide is most appropriate and when it's not. SS-31 (Elamipretide)…
Before selecting a peptide protocol, understand what each compound actually does. Not what marketing claims suggest. Thymosin Alpha-1 TLR activation → IL-2 upregulation T-cells (CD4+, Treg) 1.6mg subcutaneous 2x/week 4–8 weeks Go…
GLP-1 Agonists (Semaglutide) GLP-1 receptor activation → delayed gastric emptying, reduced appetite Fasting glucose, triglycerides, waist circumference 0.25–2.4mg weekly SC Subcutaneous injection Gold standard for multi-component…
Epitalon Telomerase activation, pineal regulation Telomere length, circadian rhythm 10mg daily subcutaneous × 10–20 days, cycled every 4–6 months Strong. Human trials show 33% telomere extension Best evidence for direct telomere …
NMN (Nicotinamide Mononucleotide) NAD+ precursor; bypasses NAMPT rate-limiting step Metabolic senescence; CD38-driven NAD+ depletion 100–500 μM (in vitro); 250–500 mg/kg (in vivo) High. Multiple RCTs, published in Science, Cell M…
Here's the honest answer: magnesium, L-theanine, glycine, and 5-HTP don't optimize sleep architecture. They might reduce sleep latency by 10–15 minutes. They might subjectively feel calming. But none of them increase slow-wave sl…
CJC-1295 with DAC GHRH receptor agonist with albumin binding 2mg weekly subcutaneous 8 days Indirect. Restores pulsatile GH → LH normalisation → testosterone synthesis Extended half-life allows weekly dosing; preserves natural GH…
Epitalon Telomerase activation via pineal-hypothalamic signaling 0.5–10 μg/g body weight Subcutaneous or intraperitoneal injection 16–33% increase in telomerase activity over 10–20 passages (human fibroblasts, Oncotarget 2019) Tr…
BPC-157 Mast cell stabilisation, VEGF/FGF upregulation Prevents histamine/cytokine release; repairs gut and BBB permeability 40–60% reduction in mast cell activation markers (neuroinflammation models, 2021) 200–500mcg daily subcu…
PT-141 (bremelanotide) Melanocortin receptor agonist MC4R (selective) 2–3 hours SC Central arousal independent of vascular function Strongest clinical evidence for arousal endpoints in both sexes. FDA-approved for FSAD Melanotan …
Before selecting a secretagogue for a specific research protocol, understand how mechanism, half-life, and side-effect profiles differ. The table below compares the four most commonly used GH-elevating peptides across the paramet…
Thymosin Alpha-1 TLR2 activation → T-cell maturation Thymic output, CD4+/CD8+ proliferation 1.6mg SC twice weekly × 8–12 weeks Phase III RCT data Gold standard for T-cell restoration. Strongest evidence base BPC-157 Tight junctio…
The following table compares the primary research peptides studied for visceral adipose tissue reduction across mechanism, administration, and documented outcomes. CJC-1295 (with DAC) GHRH receptor agonist; stimulates endogenous …
Semax BDNF upregulation, hippocampal neurogenesis via ACTH(4-10) signaling 50–300 µg/kg intranasal, daily for 7–14 days Forced swim test, learned helplessness, Morris water maze 7–10 days (chronic administration) Best choice for …
BPC-157 Enhances fibroblast migration; upregulates VEGF for angiogenesis 200–500 mcg daily Subcutaneous or intramuscular Days 3–5 through week 6 Best for accelerating collagen deposition during proliferative phase TB-500 Promotes…